Skip to main content
. 2012 Jul 26;2012:617063. doi: 10.1155/2012/617063

Table 1.

Oligonucleotide primers employed.

Gene Primer sequence Tm °C Amplicon size (bp)
9s rRNA F 5-ATCCGCCAACGTCACATT-3 57.6 115
R 5-CCGCCGCCATAAGGAGAAC-3 64.5
CD36 F 5-CAGTCGGAGACATGCTTATTGAG-3 60.7 151
R 5-TTTGCCACGTCATCTGGGTTT-3 62.5
COX-2 F 5-TGTGACTGTACCCGGACTGG-3 63.0 233
R 5'-TGCACATTGTAAGTAGGTGGAC-3 60.0
FABP4 F 5-GGGGCCAGGCTTCTATTCC-3 61.8 114
R 5-GGAGCTGGGTTAGGTATGGG-3 61.1
GAPDH F 5-GGACGCATTGGTCGTCTGG-3 63.0 204
R 5-TTTGCACTGGTACGTGTTGAT-3 60.2
IL-12 p40 F 5-CAAGGCTGTTCACATTATCCCA-3 60.3 107
R 5-CCAGTGTGGTCATGGACTTTC-3 60.6
MCP-1 F 5-TTAAAAACCTGGATCGGAACCAA-3 60.1 121
R 5-GCATTAGCTTCAGATTTACGGGT-3 60.7
NOS2 F 5-ACATCGACCCGTCCACAGTAT-3 62.7 177
R 5-CAGAGGGGTAGGCTTGTCTC-3 61.0
NOX4 F 5-TGCCTGCTCATTTGGCTGT-3 62.2 180
R 5-CCGGCACATAGGTAAAAGGATG-3 60.8
PPAR-γ F 5-CCATTCTGGCCCACCAAC-3 66.5 479
R 5-CTGAAACCGACAGTACTG-3 53.8
TNF-α F 5-CCTGTAGCCCACGTCGTAG-3 61.5 148
R 5-GGGAGTAGACAAGGTACAACCC-3 61.4
HHS Vulnerability Disclosure